Several analysts have recently updated their ratings and price targets for Fresenius Medical Care AG & Co. KGaA (ETR: FME):

  • 8/8/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €88.00 ($103.53) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 8/8/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €84.00 ($98.82) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 8/8/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.10 ($111.88) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 8/8/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €97.00 ($114.12) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 8/8/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €92.00 ($108.24) price target on by analysts at Citigroup Inc.. They now have a “buy” rating on the stock.
  • 8/7/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €88.00 ($103.53) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 8/7/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €92.10 ($108.35) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 8/3/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €93.00 ($109.41) price target on by analysts at Nord/LB. They now have a “buy” rating on the stock.
  • 8/2/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($111.76) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 8/2/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €88.00 ($103.53) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 8/2/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €83.00 ($97.65) price target on by analysts at Jefferies Group LLC. They now have a “neutral” rating on the stock.
  • 8/2/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €85.00 ($100.00) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 8/2/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €106.40 ($125.18) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 8/2/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €98.00 ($115.29) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 8/1/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($111.76) price target on by analysts at S&P Global. They now have a “buy” rating on the stock.
  • 8/1/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €88.00 ($103.53) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 8/1/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €92.10 ($108.35) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 8/1/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €68.00 ($80.00) price target on by analysts at UBS AG. They now have a “sell” rating on the stock.
  • 7/27/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €106.40 ($125.18) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 7/26/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €92.10 ($108.35) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 7/24/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €85.00 ($100.00) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 7/24/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €98.00 ($115.29) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 7/20/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($111.76) price target on by analysts at Oddo Securities. They now have a “buy” rating on the stock.
  • 7/14/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €68.00 ($80.00) price target on by analysts at UBS AG. They now have a “sell” rating on the stock.
  • 6/30/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($111.76) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 6/30/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €100.00 ($117.65) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.

Fresenius Medical Care AG & Co. KGaA (FME) opened at 78.722 on Monday. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €70.82 and a 52-week high of €89.07. The stock’s 50 day moving average price is €81.50 and its 200 day moving average price is €81.20. The firm has a market capitalization of €24.16 billion and a PE ratio of 20.300.

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Receive News & Stock Ratings for Fresenius Medical Care AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co KGaA and related stocks with our FREE daily email newsletter.